Vyas Lab retweeted
Lovely to see this one out in @Nature today:
@andygxzeng @MurtazaNagree @asger_jakobsen et al. identify an HSC subset retaining a molecular memory of inflammatory stress. A great collaboration between the @stephxie, John Dick, and @vyas_lab groups.
nature.com/articles/s41586-0…
Vyas Lab retweeted
Excited to see our study featured as a Plenary Paper in this week's issue of Blood @BloodPortfolio
ashpublications.org/blood/ar…
Podcast episode summarising the findings: share.transistor.fm/s/1ae254…
Delighted to see that our work was selected as Plenary Paper in the new issue of Blood! We show that rapid clonal selection foreshadows outcome of IVO+VEN+/-AZA in AML and uncover transcriptional processes altered in resistant clones! @BloodPortfolio
ashpublications.org/blood/ar…
Vyas Lab retweeted
Delighted to see that our work was selected as Plenary Paper in the new issue of Blood! We show that rapid clonal selection foreshadows outcome of IVO+VEN+/-AZA in AML and uncover transcriptional processes altered in resistant clones! @BloodPortfolio
ashpublications.org/blood/ar…
Vyas Lab retweeted
Delighted to see our paper in @BloodPortfolio! Amazing collaboration between the teams in the @pvyas_oxford lab and the @MDAndersonNews! @FARadtke @BilyanaStoilova Rabea Mecklenbrauck @angusgroom Courtney DiNardo @mkonople @CLachowiez @sanamloghavi
🧵 about our main findings👇
🧵Just out in Blood @BloodPortfolio: Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy
ashpublications.org/blood/ar…
We study how resistance and durable remission emerge in IDH1-mutant AML.
Vyas Lab retweeted
Great collaboration with @MDAndersonNews courtney dinardo @mkonople @CLachowiez and the top crew in our lab esp @SvenTurkalj @FARadtke @BilyanaStoilova Rabea and @angusgroom
Data that has wide implications
🧵Just out in Blood @BloodPortfolio: Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy
ashpublications.org/blood/ar…
We study how resistance and durable remission emerge in IDH1-mutant AML.
Vyas Lab retweeted
🧵Just out in Blood @BloodPortfolio: Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy
ashpublications.org/blood/ar…
We study how resistance and durable remission emerge in IDH1-mutant AML.
Vyas Lab retweeted
Our paper on detecting and quantifying clonal selection from a single bulk sequencing sample is out! This was a great collaboration with @pvyas_oxford, Thomas Höfer, @asger_jakobsen and @NaserAnsariPour. Read the full story here: nature.com/articles/s41588-0…
Vyas Lab retweeted
@SvenTurkalj kicked off the first session with an excellent talk on his new genotyping method published in @CellStemCell last month 🎉
@MRC_MHU @vyas_lab
bit.ly/43KBQOr
Well done, @GerdaMickute! You’re an asset to the lab 🙌🏻
This Post is from an account that no longer exists. Learn more
Vyas Lab retweeted
Congratulations to Prof. Irene Roberts and Prof. Paresh Vyas (@pvyas_oxford), who have been elected to Academy of Medical Sciences (@acmedsci) Fellowship! #AMSFellows2023
Read more here: bit.ly/acmed23
@MRC_MHU @RDMOxford @OxPaediatrics
Vyas Lab retweeted
Delighted to see our paper out today at @CellStemCell ! GTAC integrates #singlecell genotyping to chromatin accessibility profiling, linking genetic and epigenetic tumor evolution. Highlights👇
@pvyas_oxford @asger_jakobsen @angusgroom
authors.elsevier.com/c/1h105…
Full house for @asger_jakobsen presenting his work on DNMT3A and TET2 mutations in CHIP. Very well done 👏🏻👏🏻
Vyas Lab retweeted
Fantastic talk by @SvenTurkalj at #ASH22 this morning on our new GTAC method for combining high sensitivity genotyping with chromatin accessibility in single cells!
